Paul Buta
Advertisement
Paul Buta is COO of Optas, a provider of privacy-safe marketing solutions.
Articles by Paul Buta
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
3
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
4
Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics
5